Please use this identifier to cite or link to this item:
http://hdl.handle.net/10397/109506
DC Field | Value | Language |
---|---|---|
dc.contributor | Department of Applied Biology and Chemical Technology | en_US |
dc.creator | Chen, S | en_US |
dc.creator | Zhi, Z | en_US |
dc.creator | Wong, WL | en_US |
dc.creator | Yuan, W | en_US |
dc.creator | Sun, N | en_US |
dc.date.accessioned | 2024-11-04T01:50:25Z | - |
dc.date.available | 2024-11-04T01:50:25Z | - |
dc.identifier.issn | 0223-5234 | en_US |
dc.identifier.uri | http://hdl.handle.net/10397/109506 | - |
dc.language.iso | en | en_US |
dc.publisher | Elsevier Masson | en_US |
dc.subject | Antibiotic | en_US |
dc.subject | Combination therapy | en_US |
dc.subject | MRSA | en_US |
dc.subject | Natural products | en_US |
dc.subject | Synergy | en_US |
dc.title | Understanding the synergistic sensitization of natural products and antibiotics : an effective strategy to combat MRSA | en_US |
dc.type | Journal/Magazine Article | en_US |
dc.identifier.doi | 10.1016/j.ejmech.2024.117012 | en_US |
dcterms.abstract | Methicillin-resistant Staphylococcus aureus (MRSA) is one of the most common multi-resistant organisms found in hospital-acquired infections and is associated with high morbidity and mortality. The development of new drugs and promising therapeutic strategies against MRSA is thus an urgent request. In recent years, some natural products have been demonstrated to show great potential in improving the efficacy of antibiotics to treat various drug-resistant bacteria, particularly MRSA. In this context, we aimed to analyze systematically from the prior arts that investigated the synergy between natural products and antibiotics against MRSA. These findings not only give us a better understanding on the mechanism of actions but also shed light on the bioactive molecular scaffolds identified from diverse natural products. In the present study, we concentratedly reviewed the studies that utilized natural products to enhance the potency of conventional antibiotics against MRSA in the last decade. The timely information reported herein may give meaningful insights into the molecular design of novel and potent antibacterial agents and/or effective therapeutics to combat MRSA for practical applications. | en_US |
dcterms.accessRights | embargoed access | en_US |
dcterms.bibliographicCitation | European journal of medicinal chemistry, Available online 28 October 2024, In Press, Journal Pre-proof, 117012 | en_US |
dcterms.isPartOf | European journal of medicinal chemistry | en_US |
dcterms.issued | 2024 | - |
dc.identifier.eissn | 1768-3254 | en_US |
dc.identifier.artn | 117012 | en_US |
dc.description.validate | 202411 bcch | en_US |
dc.description.oa | Not applicable | en_US |
dc.identifier.FolderNumber | a3266 | - |
dc.identifier.SubFormID | 49854 | - |
dc.description.fundingSource | Others | en_US |
dc.description.fundingText | Health and Medical Research Fund, Hong Kong SAR | en_US |
dc.description.pubStatus | Early release | en_US |
dc.date.embargo | 0000-00-00 (to be updated) | en_US |
dc.description.oaCategory | Green (AAM) | en_US |
Appears in Collections: | Journal/Magazine Article |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.